Subscribe To
Roche's (rhhby) late-stage lung cancer study meets primary goal
Roche's (RHHBY) late-stage ALK-positive non-small cell lung cancer study evaluating Alecensa meets the ...
September 1, 2023, 9:47 am
Merck (mrk), eisai to end keytruda-lenvima combo cancer study
With the phase III LEAP-010 study failing to show an overall survival benefit for patients with recurrent or metastatic HNSCC, Merck (MRK) and Eisai h...
August 28, 2023, 12:02 pm
Novocure shares plunge after ovarian cancer study failure
Shares of Novocure Ltd. NVCR, -0.77% dropped 37% premarket on Monday after the Swiss oncology company said a late-stage trial of Tumor Treating Fields...
August 28, 2023, 8:34 am
Exelixis' (exel) prostate cancer study meets primary endpoint
Exelixis (EXEL) and partner Ipsen's phase III CONTACT-02 study meets one of the two primary endpoints in prostate cancer patients....
August 21, 2023, 12:47 pm
Seagen's (sgen) breast cancer study on tuksya combo meets goal
Seagen (SGEN) announces positive top-line results from its breast cancer study evaluating Tuksya in com...
August 17, 2023, 11:46 am
National ‘best hospitals’ rankings released: which delaware hospitals made the list?
“High performing” ratings were achieved in 13 procedures/conditions: leukemia/lymphoma/myeloma, lung cance...
August 2, 2023, 5:14 pm
Judge dismisses j&j cancer suit strategy
Johnson & Johnson cannot use a unit's bankruptcy case to press tens of thousands of cancer victims to drop their lawsuits and accept an $8.9 billion ...
August 1, 2023, 12:10 pm
Statement from the prevent cancer foundation on updated guidance for colorectal cancer screening from the american college of physicians
Alexandria, Va., July 31, 2023 (GLOBE NEWSWIRE) — The American College of Physicians (ACP) today issued updated guidance for colorectal ...
July 31, 2023, 10:13 pm
Merck's keytruda meets main goal in late-stage breast cancer study
Merck said on Friday its blockbuster drug Keytruda, in combination with chemotherapy, met one of the main goals in a late-stage trial testing it in so...
July 28, 2023, 7:28 am
7 best cancer stocks to invest in now
One of the most aggressive and difficult-to-treat ailments, cancer is a disease that involves the uncontrolled division and growth of malignant cells....
July 28, 2023, 7:00 am
The global breast cancer screening tests market is fueled by advancing imaging technologies and biomarker testing, with a projected remarkable cagr of 7.8% by 2033 | future market insights, inc.
NEWARK, Del, July 26, 2023 (GLOBE NEWSWIRE) — Future Market Insights’ latest Global Breast cancer s...
July 26, 2023, 4:30 pm
Astrazeneca earnings update comes with shares regrouping after big tumble from peak
In April, AstraZeneca PLC (LSE:AZN) hit an all-time high above £122 per share, topping former suitor Pfizer, before retreating sharply. It has been...
July 21, 2023, 12:58 pm
Ipo update: advanced biomed finalizes $112 million u.s. ipo plan
Advanced Biomed has filed proposed terms for a $112 million U.S. IPO. The firm is developing a portfolio of ca...
July 19, 2023, 1:25 pm
Oxford cannabinoid jumps as firm hints cheaper cancer treatments
Shares in Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) rose 10% on Monday as the pharmaceutical company formally announced its...
July 17, 2023, 6:06 am
Panbela (pbla) up 11% on update from pancreatic cancer study
Panbela (PBLA) rises 11% on a positive recommendation from an independent board reviewing safety data from a late-stage study of ivospemin in the trea...
July 11, 2023, 2:02 pm
Astrazeneca (azn) down 9% on mixed lung cancer study results
While AstraZeneca's (AZN) late-stage study evaluating an experimental lung cancer treatment showed improvement in progression free survival, it did no...
July 4, 2023, 12:15 pm
Analysts bullish on exact sciences' advanced cancer screening
Exact Sciences Corp. NASDAQ: EXAS is on a self-proclaimed mission to change the way cancer is detected and treated. The Madison, Wisconsin company is ...
June 23, 2023, 7:10 am
Novo nordisk shares slip on ema drug safety signal
Novo Nordisk said on Thursday the European Union's drug watchdog had last month raised a thyroid cancer s...
June 22, 2023, 3:58 am
Colposcopy market size to hit usd 0.86 billion by 2030 at 5.12% cagr – report by market research future (mrfr)
Colposcopy Market Trends and Insights By Instrument Type (Optical Colposcope, Digital Colposcope), Instrument Portability (Portable, Fixed, Handheld),...
June 22, 2023, 12:49 am
Merck's (mrk) gastric cancer study fails to meet a primary goal
Merck's (MRK) late-stage study evaluating Keytruda in advanced gastric cancer fails to meet one of the primary endpoints....
June 21, 2023, 11:49 am